Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 17NETWORK 2OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 6Gastrointestinal 3Gynecologic 2Thoracic 1Other 1Genitourinary 1Classical hematology 1

Conditions

Ovarian Neoplasms 117Uterine Cervical Neoplasms 65Carcinoma, Ovarian Epithelial 64Fallopian Tube Neoplasms 62Endometrial Neoplasms 38Brenner Tumor 22Sarcoma 18Testicular Neoplasms 15Vulvar Neoplasms 12Squamous Intraepithelial Lesions 10Sarcoma, Endometrial Stromal 10Endometrial Adenocarcinoma 10Breast Neoplasms 10Ovarian Germ Cell Cancer 9HIV Infections 9Teratoma 7Sarcoma, Synovial 7Precancerous Conditions 7Osteosarcoma 7Neurofibrosarcoma 7Neuroblastoma 7Melanoma 7Liposarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Carcinoma, Non-Small-Cell Lung 7Uterine Cervical Dysplasia 6Stomach Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Fatigue × Gynecologic × Clear all
NCT01372787 2019-03-12

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

GOG Foundation

Unknown
103 enrolled
Gynecologic

Anxiety Disorders, Fallopian Tube Neoplasms, Fatigue, Nausea, Ovarian Neoplasms, Vomiting, Neurotoxicity Syndromes

NCT01492920 2014-12-31

Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

GOG Foundation

Phase 3 Withdrawn
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Fatigue, Ovarian Neoplasms, Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡